SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001477932-23-004986
Filing Date
2023-07-03
Accepted
2023-07-03 17:15:17
Documents
64
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A nbio_10ka.htm   iXBRL 10-K/A 886415
2 CERTIFICATION nbio_ex311.htm EX-31.1 12802
3 CERTIFICATION nbio_ex312.htm EX-31.2 12730
4 CERTIFICATION nbio_ex321.htm EX-32.1 5272
5 CERTIFICATION nbio_ex322.htm EX-32.2 4257
11 nbio_10kimg2.jpg GRAPHIC 4586
12 nbio_10kimg1.jpg GRAPHIC 2975
  Complete submission text file 0001477932-23-004986.txt   4311626

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nbio-20230331.xsd EX-101.SCH 63008
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20230331_lab.xml EX-101.LAB 279976
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20230331_cal.xml EX-101.CAL 36051
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20230331_pre.xml EX-101.PRE 235800
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20230331_def.xml EX-101.DEF 131519
57 EXTRACTED XBRL INSTANCE DOCUMENT nbio_10ka_htm.xml XML 499820
Mailing Address 631 US HWY 1, SUITE 407 NORTH PALM BEACH FL 33408
Business Address 631 US HWY 1, SUITE 407 NORTH PALM BEACH FL 33408 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

IRS No.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K/A | Act: 34 | File No.: 000-55299 | Film No.: 231065948
SIC: 2834 Pharmaceutical Preparations